NewVac Signs License and Co-Development Agreement With Janssen to

NewVac Signs License and Co-Development Agreement With Janssen to

Filed under: drug treatment programs in san francisco

NewVac Signs License and Co-Development Agreement With Janssen to Advance Novel Drug for Treatment of Solid Tumors. Thursday, January 10, 2013 – NewVac LLC · Feed-icon-14×14. Page Views: 137. Currently 2.0/5 Stars. 1; 2; 3; 4; 5. Give this press …
Read more on NewsMaker (press release)

 

Heart-Block Test Could Bring Volcano, St. Jude Billion Gain

Filed under: drug treatment programs in san francisco

Volcano and St. Jude are both expanding in a “duopoly market,” Huennekens said yesterday during a presentation at the JPMorgan & Chase Co. health-care conference in San Francisco. “Will FFR continue … The technology precisely measures arterial …
Read more on Bloomberg

 

Bob Langer biotech lands first big biopharma deal with Amgen

Filed under: drug treatment programs in san francisco

At a preclinical stage, the program has a lot to prove. Yet the effort could advance … The deal boosts Amgen's lineup of experimental cancer drugs and backs up marketed products such as Vectibix, a monoclonal antibody that targets EGFR kinase to …
Read more on FierceBiotech